(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

IQTIN

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

IQTIN

ST13

US500000097160162

Classe

5

Pedido

97160162

Registro

8253890

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

48

Atualização mais recente

12/05/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5

Data de depósito

07/12/2021

Data de registro

12/05/2026

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

12/05/2026

Última transação

12/05/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Primeiro uso

22/12/2022

Primeiro uso no comércio

22/12/2022

Código do desenho

4

Tipo de titular

03

Localização do titular

Wollerau, CH

Examinador

LIU, PHILIP HUAI-EN

Unidade examinadora

L90

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

System Biologie AG

Representantes

Erik M. Pelton ERIK M. PELTON & ASSOCIATES, PLLC

Classificação técnica

Classes Nice

Classe 5

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Dietary supplements; Anti-inflammatories; Anti-inflammatory gels; Anti-inflammatory preparations; Veterinary preparationsantioxidants; Central nervous system stimulants; Extracts of medicinal herbs; Extracts of medicinal plants; Herbal compoundsherbal supplements; Herbal supplements; Immunostimulants; Immunomodulators; Medicated food supplements; Medicinal herbs; Medicinal drinks; Medicines for humansneurodegenerative and Inflammageing medicines; Medicine for neurodegenerativeepigeneticinflammation disorders; Medicinal preparations and substances for neurodegenerative and epigenetic disorders; Nutraceutical preparations for therapeutic or medical purposes in the form of a dietary supplement; Nutraceuticals for therapeutic purposes for use as a dietary supplement; Pharmaceutical preparations for preparations for the prevention of diseases of the nervous system; Pharmaceutical preparations for the prevention of diseases of the metabolic system; Pharmaceutical preparations for the prevention of diseases of the immune system; Pharmaceutical preparations for the prevention of diseases of the endocrine system; Pharmaceutical preparations for the prevention of autoimmune diseases; Pharmaceutical preparations for the treatment of Alzheimer'sParkinson'sDementia and inflammatory diseases; Phytotherapy preparations for medical purposes; Plant and herb extracts for medicinal use; Plant extracts for pharmaceutical purposes; Dietary supplement drink mixes; Dietary supplemental drinks; Dietary supplements for humans; Dietetic beverages adapted for medical purposes; Dietetic food preparations adapted for medical usenamely dietetic beverages; Dietetic foods adapted for medical purposes; Dietetic substancesnamely dietetic beverages adapted for medical use; Food supplements; Food supplements in liquid form; Liquid herbal supplements; Liquid vitamin supplements; Mineral nutritional supplements; Mineral food supplements; Nutritional supplements; Nutraceuticals for use as a dietary supplement; Nutraceutical preparations for humansnutraceuticals for use as a dietary supplements for promoting overall health

Publicações

Histórico de despachos e eventos da marca no USPTO.

48 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/05/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

12/05/2026

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

22/04/2026

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

22/04/2026

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

22/04/2026

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

22/04/2026

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/08/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

17/07/2024

GNRT

NON-FINAL ACTION E-MAILED

17/07/2024

CNRT

SU - NON-FINAL ACTION - WRITTEN

17/07/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

21/06/2024

IUAF

USE AMENDMENT FILED

20/06/2024

EISU

TEAS STATEMENT OF USE RECEIVED

20/06/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/01/2024

EX1G

SOU EXTENSION 1 GRANTED

09/01/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

09/01/2024

EXT1

SOU EXTENSION 1 FILED

18/12/2023

EEXT

SOU TEAS EXTENSION RECEIVED

18/12/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

20/06/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

25/04/2023

PUBO

PUBLISHED FOR OPPOSITION

25/04/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/04/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

22/03/2023

XAEC

EXAMINER'S AMENDMENT ENTERED

22/03/2023

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

22/03/2023

GNEA

EXAMINERS AMENDMENT E-MAILED

22/03/2023

CNEA

EXAMINERS AMENDMENT -WRITTEN

22/03/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

20/03/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

20/03/2023

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

20/03/2023

GNS1

NOTIFICATION OF SUBSEQUENT FINAL EMAILED

16/03/2023

GNCF

CONTINUATION OF FINAL REFUSAL E-MAILED

16/03/2023

CNCF

ACTION CONTINUING A FINAL - COMPLETED

16/03/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

15/03/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

15/03/2023

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

15/03/2023

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

29/12/2022

GNFR

FINAL REFUSAL E-MAILED

29/12/2022

CNFR

FINAL REFUSAL WRITTEN

29/12/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

28/10/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

28/10/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

28/10/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

16/09/2022

GNRT

NON-FINAL ACTION E-MAILED

16/09/2022

CNRT

NON-FINAL ACTION WRITTEN

16/09/2022

DOCK

ASSIGNED TO EXAMINER

15/09/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

13/12/2021

NWAP

NEW APPLICATION ENTERED

10/12/2021

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace IQTIN ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.